# Precision Oncology * **Definition:** A medical approach that uses advanced technologies and genetic information to tailor cancer treatment to individual patients, considering individual variability in genes, environment, and lifestyle to improve patient outcomes. * **Taxonomy:** Healthcare Topics / Precision Oncology ## News * Selected news on the topic of **Precision Oncology**, for healthcare technology leaders * 13.8K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/27/2025 | [**Digital Health News - HIT Consultant**](https://hitconsultant.net/category/digital-health-2/page/726/) | [[HIT Consultant]] | | 5/7/2025 | [**The Caris Precision Oncology Alliance Welcomes LSU LCMC Health Cancer Center**](https://www.prnewswire.com/news-releases/the-caris-precision-oncology-alliance-welcomes-lsu-lcmc-health-cancer-center-302447905.html) | [[PR Newswire]] | | 4/23/2025 | [**ConcertAI, Bayer join forces to advance precision oncology**](https://www.mobihealthnews.com/news/concertai-bayer-join-forces-advance-precision-oncology) | [[MobiHealthNews]] | | 3/11/2025 | [**DeepRx Inc. Appoints Mr. Wensheng Fan as CEO for the AI in Precision Oncology Company**](https://www.newswire.com/news/deep-rx-inc-appoints-mr-wensheng-fan-as-ceo-for-the-ai-in-precision-22536180) | [[Newswire]] | | 3/6/2025 | [**Global AI in Cancer Diagnostics Market to Observe Stunning Growth at a CAGR ~11y 2032 - DelveInsight**](https://www.globenewswire.com/news-release/2025/03/06/3038528/0/en/Global-AI-in-Cancer-Diagnostics-Market-to-Observe-Stunning-Growth-at-a-CAGR-11-by-2032-DelveInsight.html) | [[Globe Newswire]] | | 2/11/2025 | [**AI-Powered Healthcare: Breakthroughs, Policies & Future Trends - Raouf Hajji, MD, PhD.**](https://www.linkedin.com/pulse/ai-powered-healthcare-breakthroughs-policies-future-hajji-md-phd--oaanf) | [[Linkedin]] | | 1/29/2025 | [**PESG Report: Silexion Therapeutics' Systemic Delivery Breakthrough Positions Company ...**](https://finance.yahoo.com/news/pesg-report-silexion-therapeutics-systemic-145900692.html) | [[Yahoo Finance]] | | 12/20/2024 | [**Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care**](http://www.businesswire.com/news/home/20241220937037/en/Meaningful-Insights-Biotech-Analytics-MiBA-and-Guardant-Health-Announce-Strategic-Partnership-to-Optimize-Use-of-Biomarker-Testing-and-Data-Analytics-to-Improve-Cancer-Care/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/20/2024 | [**Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic ...**](https://finance.yahoo.com/news/meaningful-insights-biotech-analytics-miba-130500989.html) | [[Yahoo Finance]] | | 12/20/2024 | [**Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care**](http://www.businesswire.com/news/home/20241220937037/en/Meaningful-Insights-Biotech-Analytics-MiBA-and-Guardant-Health-Announce-Strategic-Partnership-to-Optimize-Use-of-Biomarker-Testing-and-Data-Analytics-to-Improve-Cancer-Care/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/17/2024 | [**Caris Life Sciences Appoints Dr. James Hamrick as Chairman of the Caris Precision ...**](https://www.prnewswire.com/news-releases/caris-life-sciences-appoints-dr-james-hamrick-as-chairman-of-the-caris-precision-oncology-alliance-302332807.html) | [[PR Newswire]] | | 12/15/2024 | [**Closing the Gap: Advancing Precision Oncology Through Education and Collaboration**](https://medcitynews.com/2024/12/closing-the-gap-advancing-precision-oncology-through-education-and-collaboration/) | [[MedCity News]] | | 11/28/2024 | [**Exosome Diagnostics & Therapeutics Market Assessment 2025-2030 Featuring Strategic ...**](https://finance.yahoo.com/news/exosome-diagnostics-therapeutics-market-assessment-115600447.html) | [[Yahoo Finance]] | | 11/21/2024 | [**OneCell Diagnostics Raises $16M for Genomics-Based Precision Oncology Platform -**](https://hitconsultant.net/2024/11/21/onecell-diagnostics-raises-16m-for-genomics-based-precision-oncology-platform/) | [[HIT Consultant]] | | 11/20/2024 | [**OneCell Diagnostics, Inc. Announces Oversubscribed Series A Funding Round to Accelerate Proprietary Cell Biopsy Technology to Democratize Precision Oncology**](https://www.prnewswire.com/news-releases/onecell-diagnostics-inc--announces-oversubscribed-series-a-funding-round-to-accelerate-proprietary-cell-biopsy-technology-to-democratize-precision-oncology-302311843.html) | [[PR Newswire]] | | 11/19/2024 | [**ICPO Foundation partners with Munich Precision Oncology (MPO) to establish dedicated theranostics centers globally**](https://www.globenewswire.com/news-release/2024/11/19/2983264/0/en/ICPO-Foundation-partners-with-Munich-Precision-Oncology-MPO-to-establish-dedicated-theranostics-centers-globally.html) | [[Globe Newswire]] | | 11/19/2024 | [**ICPO Foundation partners with Munich Precision Oncology (MPO) to establish dedicated ...**](https://finance.yahoo.com/news/icpo-foundation-partners-munich-precision-063000615.html) | [[Yahoo Finance]] | | 11/18/2024 | [**ICPO Foundation partners with Munich Precision Oncology (MPO) to establish dedicated theranostics centers globally**](https://markets.businessinsider.com/news/stocks/icpo-foundation-partners-with-munich-precision-oncology-mpo-to-establish-dedicated-theranostics-centers-globally-1034034132) | [[Business Insider Markets]] | | 10/3/2024 | [**VieCure Secures 45M for AI-Enabled Community Oncology Care Platform**](https://hitconsultant.net/2024/10/03/viecure-secures-45m-for-ai-enabled-community-oncology-care-platform/) | [[HIT Consultant]] | | 9/13/2024 | [**MASSIVE BIO AND FOUNDATION MEDICINE PARTNER TO EXPAND ACCESS TO ... - EIN News**](https://tech.einnews.com/pr_news/742837494/massive-bio-and-foundation-medicine-partner-to-expand-access-to-precision-cancer-care) | tech.einnews.com | | 9/1/2024 | [**Xtalks Announces its Life Science Webinar Calendar for September 2024**](https://www.prweb.com/releases/xtalks-announces-its-life-science-webinar-calendar-for-september-2024-302235364.html) | [[PRWeb]] | | 7/25/2024 | [**The Caris Precision Oncology Alliance Welcomes The University of Mississippi Medical Center**](https://www.prnewswire.com/news-releases/the-caris-precision-oncology-alliance-welcomes-the-university-of-mississippi-medical-center-302205403.html) | [[PR Newswire]] | | 7/17/2024 | [**Data Privacy in Healthcare: Balancing Innovation with Patient Security**](https://www.healthcareittoday.com/2024/07/17/data-privacy-in-healthcare-balancing-innovation-with-patient-security/) | [[Healthcare IT Today]] | | 6/26/2024 | [**An AI tool's potential impact on predictive medicine**](https://medicalxpress.com/news/2024-06-ai-tool-potential-impact-medicine.html) | [[MedicalXpress]] | | 6/13/2024 | [**Flinn Foundation-Sponsored Study Identifies Three Bioscience Growth Areas to Advance Innovation and Economic Growth in Greater Phoenix**](http://www.businesswire.com/news/home/20240613324046/en/Flinn-Foundation-Sponsored-Study-Identifies-Three-Bioscience-Growth-Areas-to-Advance-Innovation-and-Economic-Growth-in-Greater-Phoenix/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Perthera**: A leader in precision oncology decision support, utilizing AI to provide personalized therapy options based on multi-omic molecular profiles. - **BostonGene**: Focuses on precision oncology solutions for breast cancer patients, utilizing advanced computational biology and AI to enhance treatment efficacy. - **SOPHiA GENETICS**: A company that launched a comprehensive genomic profiling application to enhance precision oncology access globally. - **Arbele**: Engaged in strategic collaborations to enhance targeted immunotherapeutics in precision oncology. - **Guardant Health**: Specializes in precision oncology through advanced blood and tissue tests, enhancing patient care and cancer outcomes. - **Labcorp**: A global leader in laboratory services that has developed innovative genomic profiling tests for precision oncology. - **Telix Pharmaceuticals**: A company focused on precision oncology, particularly in developing theranostic radiopharmaceuticals. - **COTA Inc.**: Offers real-world data and analytics resources to improve cancer therapy development and patient care. - **OneCell Diagnostics**: A genomics-based startup focused on precision oncology, utilizing proprietary blood-based biopsy technology to detect cancer recurrence. - **Caris Life Sciences**: A company that operates the Precision Oncology Alliance, a global network of cancer centers focused on advancing precision medicine. - **ConcertAI**: A company that leverages AI and machine learning capabilities to enhance precision oncology initiatives, integrating clinical, genomic, and imaging data for improved treatment insights. - **Foundation Medicine**: Offers precision medicine solutions that integrate genomic data to inform treatment decisions. - **IMAC Holdings**: Launched a precision oncology assay for breast cancer treatment decision-making through its subsidiary Ignite Proteomics. - **DeepRx Inc.**: Focused on leveraging AI to revolutionize personalized medicine, with COLOXIS as its flagship product for optimizing chemotherapy drug selection. ### Partnerships and Collaborations - **COTA and Texas Oncology**: A partnership to integrate machine learning into precision oncology, utilizing genetic information to personalize cancer treatment. - **Caris Precision Oncology Alliance**: A global network of 96 member institutions collaborating to advance precision oncology and improve clinical outcomes. - **International Centers for Precision Oncology Foundation and Munich Precision Oncology GmbH**: A partnership to establish a pilot center for advanced radiomolecular cancer treatments. - **Onco-Innovations and Inka Health**: An acquisition aimed at enhancing precision oncology through AI technology. - **LSU LCMC Health Cancer Center and Caris Precision Oncology Alliance**: Joining a global network to advance precision oncology and biomarker-driven research. - **Caris Life Sciences and Mass General Cancer Center**: Expanded the Precision Oncology Alliance to improve patient outcomes through precision medicine. - **International Centers for Precision Oncology (ICPO) and American Hospital Dubai**: Collaborating to enhance educational standards for radiotheranostics and improve patient access to advanced cancer therapies. - **Guardant Health and Policlinico Gemelli**: Established an in-house liquid biopsy testing service in Italy to enhance cancer diagnostics. - **Massive Bio and Foundation Medicine**: A strategic collaboration aimed at increasing patient access to clinical trials by combining AI-driven patient matching with genomic profiling. - **Bayer and ConcertAI**: A multi-year agreement to enhance precision oncology initiatives using ConcertAI's Translational360 database and AI analytical software. - **Acurion**: Rebranded to focus on actionable genomic information, aiming to reduce the time from cancer diagnosis to treatment through its AI platform. - **COTA Inc. and Guardant Health**: Collaboration to provide biopharmaceutical researchers access to combined datasets for optimizing drug development. - **Yuhan Corporation and KAIST**: A collaboration aimed at revolutionizing cancer treatment through AI-driven research, focusing on personalized lung cancer therapies. - **J INTS BIO and Yonsei University**: Launched an AI-driven collaboration to develop personalized lung cancer therapies. - **ICPO and Nuclear Medicine Research Infrastructure (NuMeRI)**: Establishing a theranostics center in South Africa to enhance global educational benchmarks in radiotheranostics. - **Viz.ai and Addario Lung Cancer Medical Institute**: Working together to improve early detection and treatment of lung cancer through AI technology. - **Gene Solutions and NEWCL Biomedical Laboratory**: A partnership to establish an advanced NGS laboratory in Taiwan, enhancing prenatal and oncology genetic testing services. - **UC San Diego and DeepHRD**: Developed an AI tool for rapid detection of genomic alterations from tumor biopsy slides. - **Guardant Health and MiBA**: Partnered to enhance precision medicine through improved biomarker testing and data analytics. ### Innovations, Trends, and Initiatives - **Functional Precision Oncology**: Enhances cancer treatment by testing a patient's live tumor outside the body to identify the most effective therapies, potentially doubling response rates. - **AI and Machine Learning**: Transforming precision oncology by enabling personalized treatment pathways and predictive modeling. - **SAGE Oncotest™**: A platform for cancer treatment optimization, providing actionable insights for personalized treatment strategies. - **AI in Precision Oncology**: The integration of AI and multi-omics technology to enhance drug efficacy and minimize toxicity in cancer therapies. - **Precision Care Companion (PCC)**: Introduced by McKesson to assist cancer practices in integrating precision medicine into daily operations, enhancing genomic testing workflows. - **Cancer Identification and Precision Oncology Center (CIPOC)**: A new initiative at UNC-Chapel Hill aimed at enhancing cancer diagnosis and personalized treatment through AI technology. - **OncoGaze™ Platform**: Acurion's AI platform that identifies genomic biomarkers from tumor biopsy slides in seconds, aiming to improve patient care. - **MSK-IMPACT® powered with SOPHiA DDM™**: A genomic profiling application aimed at improving tumor profiling accuracy and minimizing misclassification risks. - **Liquid Biopsy Technology**: Revolutionizing cancer treatment by providing real-time insights into cancer progression, enabling personalized interventions. - **Digital Pathology**: Utilizes AI algorithms for enhanced cancer detection and tumor classification, improving patient outcomes. - **Hyper-personalized Medicine**: Tailoring treatments based on genetic makeup, environment, and lifestyle, driven by advancements in genomics and data analytics. - **PGDx elio plasma focus Dx**: The first kitted pan-solid tumor liquid biopsy test approved by the FDA, allowing genomic profiling from blood samples. - **ctDNA Testing**: Emerging as a less invasive method for cancer detection and monitoring, with ongoing research to integrate it into clinical workflows. - **AI in Oncology**: Azra AI's solutions are designed to automate oncology workflows, improving healthcare provider satisfaction and patient routing. - **Genomics in Precision Medicine**: Bumrungrad International Hospital's initiatives to integrate genomic technology into clinical workflows for tailored cancer treatments. - **RPPA Technology**: IMAC Holdings' assay utilizes Reverse Phase Protein Array technology for breast cancer treatment decision-making. - **Guardant360® CDx**: A liquid biopsy test that received European certification for comprehensive tumor mutation profiling. ### Challenges and Concerns - **Integration of Functional Precision Oncology**: Despite its promise, functional precision oncology is not widely available in cancer centers, and many oncologists remain unaware of its benefits. - **Access Disparities**: Limited access to genomic testing and tumor biopsies, particularly among underserved communities, hinders the adoption of precision oncology. - **High Technology Costs**: The high costs associated with advanced technologies in precision oncology can hinder widespread adoption. - **Cost and Adoption Barriers**: High costs and slow turnaround times limit the adoption of precision oncology technologies. - **Regulatory Hurdles**: Regulatory challenges can slow down the development and implementation of new precision oncology therapies. - **Geographic Diversity in Trials**: Challenges in recruiting geographically diverse patient populations for clinical trials can limit the effectiveness of precision oncology. - **Health Inequalities**: Delays and disparities in access to precision medicine hinder timely treatment for cancer patients. - **Access to Biomarker Testing**: Challenges in accessing PD-L1 biomarker testing results due to the unstructured nature of laboratory reports requiring clinical expertise for interpretation. - **Clinical Trial Enrollment**: Less than 8% of eligible cancer patients participate in trials, highlighting the need for improved recruitment strategies. - **Clinical Trial Participation**: Less than 10% of cancer patients participate in clinical trials, highlighting the need for improved patient recruitment strategies. - **Reimbursement Cuts for Oncology Providers**: Concerns regarding potential reimbursement cuts due to drug price negotiations under the Inflation Reduction Act. - **Barriers in Screening**: A survey revealed that oncologists attribute the rise in late-stage cancer diagnoses to barriers in screening and access to quality cancer care. - **Implementation Costs**: High costs and interoperability issues hinder the widespread adoption of precision medicine software. - **Cost and Accessibility Issues**: Traditional genomic testing methods often face challenges related to cost and accessibility, impacting patient care. - **Delays in Patient Recruitment**: Traditional centralized models for assessing eligibility can lead to delays in patient recruitment and treatment. - **Patient Consent**: Ethical implications of monetizing patient data and the need for careful consideration of patient consent in data usage. - **Regulatory Compliance**: Navigating complex regulatory challenges is essential for startups in the European medtech landscape. - **Ethical Considerations**: Concerns regarding patient privacy and responsible AI use as AI integrates with clinical data. - **Data Privacy and Security**: Concerns regarding the secure handling of sensitive patient data in the context of advanced AI and digital health technologies. ## Related Topics [[Oncology]]; [[Medical Oncology]]; [[Surgical Oncology]]; [[Pediatric Oncology]]; [[Precision Medicine]]